CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Gustav A. Christensen, President and Chief Executive Officer of Dyax, will present at the Deutsche Bank 35th Annual Health Care Conference, being held May 3-5th at the InterContinental Hotel in Boston, MA. Mr. Christensen will present a corporate progress report, including an update on the Company’s commercial activities for KALBITOR® (ecallantide) and clinical development programs. The Dyax presentation is scheduled for Wednesday, May 5th at 10:00 AM (ET).
